(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 3. Alterations of Her6 and Her4 expression disrupt paraxial mesoderm segmentation and AP somitic polarity without affecting the specification of A or P somitic compartments. Dorsal view of whole-mounted (A-C,H-J) or flat-mounted embryos at 7-15 ss. Anterior is towards the top. Two-cell stage embryos were injected in one cell only. In all cases, the injected side is on the right, the control non-injected side on the left. Red (D,E,G,K,L,N) or brown (O) staining marks the tracer co-injected with the various mRNAs. (A-C,H-J) Embryos injected with wt-her6 or her6VP16 mRNAs, have abnormal somites with irregular boundaries. Living embryos injected with wt-her6 (A) or her6VP16 (H) and lacZ mRNA as a lineage tracer. (B,I) The same embryos as in A and H, respectively, after fixation and X-gal staining. (C,J) Higher magnification views of the anterior somites of living embryos injected with wt-her6 and her6VP16, respectively. (D,K,O) In embryos injected with wt-her6, her6VP16 and wt-her4, respectively, the segmental expression of myod in the paraxial mesoderm is irregular. (E,F,L,M,P) Expression of A (lfng, papc) and P (ephrinB2) somite compartment markers is disrupted in embryos with altered expression and/or function of Her6 and Her4. Identical abnormalities are observed for lfng in wt-her6-injected embryos (E) and for ephrinB2 in her6VP16-injected embryos (L). Markers are irregularly expressed throughout the segmented paraxial mesoderm. The segmental expression pattern of papc, which is normally restricted to the prospective A compartment of the forming and newly formed somites, is disorganised in embryos injected with wt-her6 (F), her6-VP16 (M) or wt-her4 (P). (G,N) Alterations of Her6 expression or function do not affect the determination of the A somitic compartment. Injection of wt-her6 (G) or her6-VP16 (N) both disrupt the expression pattern of the A compartment specification gene, mespb, without leading to its up- or downregulation compared with the control noninjected side.